nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Bradykinin and the therapeutic actions of angiotensin-converting enzyme inhibitors
|
Berkenboom, Guy |
|
1998 |
82 |
10S1 |
p. S11-S13 3 p. |
artikel |
2 |
Cardioprotective effects of postmenopausal hormone treatment
|
Espeland, Mark A. |
|
1998 |
82 |
10S1 |
p. S37-S39 3 p. |
artikel |
3 |
Cardiovascular effects of soybean phytoestrogens
|
Clair, Richard St. |
|
1998 |
82 |
10S1 |
p. S40-S42 3 p. |
artikel |
4 |
Disruption of the endothelial nitric oxide synthase gene: Effect on vascular response to injury
|
Huang, Paul L. |
|
1998 |
82 |
10S1 |
p. S57-S59 3 p. |
artikel |
5 |
Effect of the angiotensin-(1–7) peptide on nitric oxide release
|
Brosnihan, K.Bridget |
|
1998 |
82 |
10S1 |
p. S17-S19 3 p. |
artikel |
6 |
Effect of treatment on survival in an animal model of chronic heart failure
|
Bastien, Natacha |
|
1998 |
82 |
10S1 |
p. S50-S52 3 p. |
artikel |
7 |
Effects of antihypertensive agents on endothelial dysfunction: Rationale for the brachial artery normalization of forearm function study
|
Charbonneau, François |
|
1998 |
82 |
10S1 |
p. S34-S36 3 p. |
artikel |
8 |
Effects of aspirin on endothelial dysfunction in atherosclerosis
|
Quyyumi, Arshed A. |
|
1998 |
82 |
10S1 |
p. S31-S33 3 p. |
artikel |
9 |
Factors involved in the maintenance of endothelial function
|
Drexler, Helmut |
|
1998 |
82 |
10S1 |
p. S3-S4 2 p. |
artikel |
10 |
Gene therapy for hypertension: Antisense inhibition with adeno-associated viral vector delivery targeting angiotensin II type 1-receptor messenger ribonucleic acid
|
Phillips, M.Ian |
|
1998 |
82 |
10S1 |
p. S60-S62 3 p. |
artikel |
11 |
Hypertension, heart failure, and endothelial function
|
Drexler, Helmut |
|
1998 |
82 |
10S1 |
p. S20-S22 3 p. |
artikel |
12 |
Impact of endothelin-1 on vascular structure and function
|
Stewart, Duncan J. |
|
1998 |
82 |
10S1 |
p. S14-S16 3 p. |
artikel |
13 |
Introduction
|
Pepine, Carl J. |
|
1998 |
82 |
10S1 |
p. S1-S2 2 p. |
artikel |
14 |
Modulation of arterial thrombosis by angiotensin-converting enzyme inhibition and angiotensin II type 1-receptor blockade
|
Mehta, Jawahar L. |
|
1998 |
82 |
10S1 |
p. S53-S56 4 p. |
artikel |
15 |
Nutriceuticals for cardiovascular health
|
Cooke, John P. |
|
1998 |
82 |
10S1 |
p. S43-S46 4 p. |
artikel |
16 |
Overview of angiotensin II-receptor antagonists
|
Pitt, Bertram |
|
1998 |
82 |
10S1 |
p. S47-S49 3 p. |
artikel |
17 |
Potential mechanisms for the effect of angiotensin-converting enzyme inhibitors on endothelial dysfunction: The role of nitric oxide
|
Cannon III, Richard O. |
|
1998 |
82 |
10S1 |
p. S8-S10 3 p. |
artikel |
18 |
Primary and secondary prevention of coronary artery disease: Trials of lipid lowering with statins
|
Pearson, Thomas A. |
|
1998 |
82 |
10S1 |
p. S28-S30 3 p. |
artikel |
19 |
The effects of angiotensin-converting enzyme inhibition on endothelial dysfunction: Potential role in myocardial ischemia
|
Pepine, Carl J. |
|
1998 |
82 |
10S1 |
p. S23-S27 5 p. |
artikel |
20 |
The role of tissue angiotensin-converting enzyme (ACE): Studies of ACE mutant mice
|
Bernstein, Kenneth E. |
|
1998 |
82 |
10S1 |
p. S5-S7 3 p. |
artikel |
21 |
Vascular endothelial growth factor: Gene therapy and therapeutic angiogenesis
|
Isner, Jeffrey M. |
|
1998 |
82 |
10S1 |
p. S63-S64 2 p. |
artikel |